Last Updated: November 16, 2026

Details for Patent: 12,138,278

« Back to Dashboard


Which drugs does patent 12,138,278 protect, and when does it expire?

Patent 12,138,278 protects CABTREO and is included in one NDA.

This patent has twelve patent family members in ten countries.

Summary for Patent: 12,138,278
Title:Topical compositions
Abstract:The disclosure provides a topical gel formulation comprising 1-1.5 wt. % clindamycin phosphate, 2.5-3.5 wt. % benzoyl peroxide, and 0.1-0.2 wt. % adapalene, in combination with a gelling agent, a polyhydric alcohol, and water, useful in treating inflammatory skin conditions, including acne, together with methods of making and using the same.
Inventor(s):Varsha Bhatt, Radhakrishnan Pillai, Arturo Angel
Assignee: Bausch Health Ireland Ltd
Application Number:US18/639,630
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 12,138,278
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Drugs Protected by US Patent 12,138,278

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bausch CABTREO adapalene; benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 216632-001 Oct 20, 2023 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 12,138,278

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2020322173 ⤷  Start Trial
Canada 3149296 ⤷  Start Trial
China 114126582 ⤷  Start Trial
China 119837892 ⤷  Start Trial
Colombia 2022002253 ⤷  Start Trial
European Patent Office 4007566 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.